RhumbLine Advisers’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-46,413
Closed -$139K 3353
2022
Q1
$139K Buy
46,413
+13,506
+41% +$29.7K ﹤0.01% 2834
2021
Q4
$42K Sell
32,907
-34
-0.1% -$68 ﹤0.01% 2986
2021
Q3
$74K Buy
32,941
+3,411
+12% +$12.3K ﹤0.01% 3012
2021
Q2
$168K Buy
+29,530
New +$196K ﹤0.01% 2935

RhumbLine Advisers's TLMD Position: Q2 2022 in Review

RhumbLine Advisers sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 46,413 shares — an estimated $139K sold.

RhumbLine Advisers first reported a position in TLMD in Q2 2021 and held it in 4 quarters. The position peaked at $168K in Q2 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

  • RhumbLine Advisers reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 46,413 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $139K.
  • RhumbLine Advisers first reported a position in SOC Telemed, Inc. Class A Common Stock in Q2 2021 and held it in 4 quarters.
  • RhumbLine Advisers's SOC Telemed, Inc. Class A Common Stock position peaked at $168K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.